SlideShare une entreprise Scribd logo
1  sur  9
Télécharger pour lire hors ligne
https://doi.org/10.1177/2048872619840876
European Heart Journal: Acute Cardiovascular Care
2019, Vol. 8(4) 379­–387
© The European Society of Cardiology 2019
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/2048872619840876
journals.sagepub.com/home/acc
Introduction
Left ventricular free-wall rupture (LVFWR) may represent
a dramatic and life-threatening event, occurring in up to 2%
of patients with acute myocardial infarction (AMI).1,2 The
clinical presentation varies from a catastrophic blowout
type characterized by cardiogenic shock and eventually
cardiac arrest, to the oozing type with haemodynamic insta-
bility and pericardial effusion.3
Prompt diagnosis and management can lead to success-
ful treatment for LVFWR. Conservative strategies have
been described,4,5 but the poor results of this treatment
make surgical intervention generally mandatory. Despite
different surgical approaches having been proposed, in-
hospital mortality continues to be high6,7 and the most
appropriate surgical management remains still controver-
sial, particularly in terms of rupture recurrence or other
type of post-operative complications.
This review describes the approaches reported in the lit-
erature regarding the management of this mechanical com-
plication of AMI.
Treatment strategies for
post-infarction left ventricular
free-wall rupture
Matteo Matteucci1,2, Dario Fina3,4, Federica Jiritano1,5,
Paolo Meani1,4, W Matthijs Blankesteijn6, Giuseppe Maria Raffa7,
Mariusz Kowaleski8, Samuel Heuts1, Cesare Beghi2,
Jos Maessen1,9 and Roberto Lorusso1,9
Abstract
Left ventricular free-wall rupture is one of the most fatal complications after acute myocardial infarction. Surgical
treatment of post-infarction left ventricular free-wall rupture has evolved over time. Direct closure of the ventricular
wall defect (linear closure) and resection of the infarcted myocardium (infarctectomy), with subsequent closure of the
created defect with a prosthetic patch, represented the original techniques. Recently, less aggressive approaches, either
with the use of surgical glues or the application of collagen sponge patches on the infarct area to cover the tear and
achieve haemostasis, have been proposed. Despite such modifications in the therapeutic strategy and surgical treatment,
however, postoperative in-hospital mortality may be as high as 35%. In extremely high-risk or inoperable patients, a non-
surgical approach has been reported.
Keywords
Cardiac rupture, myocardial infarction, surgical treatment, mechanical complication
Date received: 29 January 2019; accepted: 28 February 2019
1Department of Cardiothoracic Surgery, Heart and Vascular Centre,
Maastricht University Medical Centre, The Netherlands
2Department of Cardiac Surgery, Circolo Hospital, University of
Insubria, Varese, Italy
3Department of Cardiology, IRCCS Policlinico San Donato, University
of Milan, Italy
4Department of Cardiology, Heart and Vascular Centre, Maastricht
University Medical Centre, The Netherlands
5Department of Cardiac Surgery, University Magna Graecia of
Catanzaro, Italy
6Department of Pharmacology and Toxicology, Cardiovascular Research
Institute Maastricht, Maastricht University, The Netherlands
7Department for the Treatment and Study of Cardiothoracic Diseases
and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy
8Clinical Department of Cardiac Surgery, Central Clinical Hospital of
the Ministry of Interior in Warsaw, Poland
9Cardiovascular Research Institute Maastricht, Maastricht University,
The Netherlands
Corresponding author:
Matteo Matteucci, Cardiothoracic Surgery Department – Heart 
Vascular Centre, Maastricht University Medical Centre (MUMC), P.
Debyelaan, 12 – 6221 AZ, Maastricht, The Netherlands.
Email: teo.matte@libero.it
840876ACC European Heart Journal: Acute Cardiovascular CareMatteucci et al.
Review
380	 European Heart Journal: Acute Cardiovascular Care 8(4)
History
The first free-wall rupture of the heart after AMI was
described by William Harvey in 1647.8 In 1769, Morgagni
collected and reported 11 cases of myocardial rupture dis-
covered postmortem9 (Figure 1). Ironically, Morgagni him-
self later died of ventricular rupture. Duaine, in 1871,
reported the first large series of patients with cardiac rup-
ture and concluded that rupture never occurs spontane-
ously.10 However, it was not until 1925, in the report of
Krumbhaar and Crowell, that the relationship of LVFWR to
myocardial infarction was first pointed out.11
Hatcher and associates, from Emory University, in 1970
described the first successful operation for free-wall rup-
ture of the right ventricle.12 Two years later, Fitzgibbon
et al. reported the successful repair of LVFWR associated
with ischaemic heart disease.13 Cardiac rupture was treated,
on cardiopulmonary bypass (CPB), with infarctectomy and
closure of the myocardial defect. In the same year, Montegut
described the history of a 58-year-old man who was suc-
cessfully treated for post-infarction LVFWR with direct
suture.10
In 1973, Calick et al. reported the surgical repair of rup-
tured myocardium with a Dacron® patch placed over the
area of perforation.14 Ten years later, Nunez and colleagues
described post-AMI free-wall ventricular rupture in seven
patients who underwent surgical intervention.15 The control
of haemorrhage was obtained by covering the ventricular
tear and the surrounding infarcted myocardium with a
Teflon® patch fixed on epicardium by a continuous
Prolene® suture.15
The first attempt to repair LVFWR with a patch fixed
with glue over the area of rupture was reported by Löfström
and associates in 1972, but the Dacron® patch loosened
soon after the operation, causing the patient’s death.16 In
1993, the first series of patients successfully treated with a
Figure 1.  Morgagni’s description of a case of ventricular wall rupture.
Frontispiece of De sedibus, et causis morborum per anatomen indagatis (JB Morgagni, 1765), with a portrait of Morgagni and Morgagni’s description
(‘Epistola anatomico-medica XXVII’) of a case of ventricular wall rupture (by courtesy of the Medical Library of Spedali Civili, Brescia, Italy).
Matteucci et al.	 381
sutureless epicardial patch technique was described.3 Padró
and colleagues successfully treated 13 patients with suba-
cute LVFWR using a Teflon® patch fixed onto the heart
surface with only surgical glue.3
Operative strategies
Clinical presentation and course are variable, depending on
the location, the size and the time-course of the rupture.17
Although acute LVFWR is often fatal, some patients with
subacute or contained rupture present with a window of
opportunity for intervention.18,19 Thereby, the diagnosis or
even a high suspicion of cardiac rupture represents an indi-
cation for emergency surgery without further delay.
The most important diagnostic method for LVFWR is
transthoracic echocardiography: the presence of reduced
myocardial wall thickness, haemopericardium or epicardial
clots and cardiac tamponade are the most relevant
findings.20 In suitable patients, cardiac magnetic resonance
can complement the diagnosis by identifying contained
ventricular rupture.21 Pericardiocentesis prior to surgery,
which confirms a haemorrhagic effusion, may further sup-
port the diagnosis, but the definitive diagnosis is usually
made at surgery.
Rarely, the rupture of the free-wall of the left ventricle is
contained by epicardial clots or pericardial adhesions, lead-
ing to the formation of a pseudoaneurysm. Left ventricular
pseudoaneurysm (LVPA) that occurs a few days after AMI
may be unstable and tends to rupture.22 Since the clinical
presentation of this condition is variable, ranging from une-
ventful condition to congestive heart failure, or even sud-
den death,23 a high index of suspicion for this serious
complication of AMI is paramount. Diagnosis can be made
by several imaging techniques, including echocardiogra-
phy, computed tomography, ventriculography and mag-
netic resonance imaging (MRI). Echocardiography is the
first-line imaging modality in suspected LVPA. Colour-
Doppler can help to demonstrate the discontinuity of the
ventricular wall and highlight the distinctive bi-directional
flow between the extracardiac echo-free space and the left
ventricle.24 Contrast ventriculography has the likelihood of
establishing a definitive diagnosis23 and can help along
with coronary angiography in surgical planning; however,
it is an invasive procedure that might precipitate ventricular
rupture. Owing to its ability to visualize the heart in precise
detail, MRI can provide essential information to confirm
diagnosis and clearly elucidate the characteristics of the
pseudoaneurysm and guide surgical intervention.25
However, MRI can be performed only in patients with
LVPA who remain haemodynamically stable. When the
diagnosis of LVPAis established, surgical correction is usu-
ally mandatory because onset of rupture is unpredictable.
On the way to surgery, restoration of a satisfactory
haemodynamic state may require inotropic support, intra-
venous fluid, intra-aortic balloon pump (IABP) and peri-
cardial drainage, as guided by clinical status (Figure 2).
Pericardiocentesis may relieve cardiac tamponade and
improve circulation in a critical situation; however, it is
often unhelpful because much of the pericardial space is
taken up by non-drainable clots. Decompression of the
pericardium may also be obtained by subxiphoid drainage
or by a classic sternotomy. In the presence of refractory
cardiac arrest, extracorporeal membrane oxygenation
might provide a chance to perform definitive surgical
treatment.26
Different opinions are published about the opportunity
to perform coronary angiograms or avoid this investigation
in order to ‘save time’.17,27 Some authors believe that coro-
nary angiography should be promptly performed as soon as
pericardial effusion is noted in AMI patients, before they
deteriorate.28,29 The knowledge of coronary status is of
great help in deciding where and how to place the sutures
during surgery; in addition, a proper revascularization of
the diseased vessels supplying the non-infarcted area at the
time of LVFWR repair (concomitant coronary artery bypass
grafting) has been shown to exert a positive impact on sur-
vival and freedom from angina.29,30
Patients being operated for post-AMI LVFWR are gen-
erally unstable, so exposure of the femoral vessels at the
groin and circuit preparation for rapid institution of CPB
should be considered before thoracic incision. The use of
CPB support, however, is a matter of controversy. Some
authors, in fact, believe that in certain circumstances
(anterior defect, haemodynamic stability, oozing type rup-
ture, sub-acute course), and with the application of par-
ticular surgical techniques (epicardial patch covering,
sutureless repair), LVFWR can be safely treated without
utilizing CPB.28
The post-operative use of IABP, and other mechanical
circulatory support, should always be taken into considera-
tion because they can reduce the intra-cavitary pressure of
the left ventricle, increase coronary blood flow and limit or
prevent the development of low cardiac output syn-
drome.17,31 Timóteo and colleagues reported that the use of
IABP in patients with post-AMI mechanical complications
was associated with improved in-hospital outcome.32
However, the European Society of Cardiology/European
Association for Cardio-Thoracic Surgery Guidelines on
myocardial revascularization allocate short-term mechani-
cal circulatory support, in the presence of post-AMI
mechanical complications, in Class of recommendation
IIb.33 Further investigations are required to better evaluate
the efficacy and safety of mechanical devices in the setting
of post-infarction LVFWR repair. General principles of
post-operative care, after LVFWR repair, are shown in
Figure 3.
Surgical materials
In the past, surgical treatment of LVFWR was generally
achieved using only Prolene® sutures, buttressed or not
with Teflon® felt. In recent years, however, cardiac
382	 European Heart Journal: Acute Cardiovascular Care 8(4)
procedures have employed patches and surgical glues.
Different materials have been proposed in patch-based
repairs. The most common applied are: Teflon®,15
Goretex®,34 Dacron®35 and pericardium,36 either autolo-
gous or xenograft. Collagen sponges, or fleeces, have been
utilized in other surgical specialties, ranging from gynae-
cology, urology and liver surgery.37,38 The use of collagen
sponges in cardiac surgery is not new; its safety has been
assessed in different cardio-thoracic procedures.39 However,
the indication for using TachoComb® or TachoSil® patches
in LVFWR repair has become more common only in recent
years, based on preliminary favourable results.40,41
Adhesives reported to be successful in the treatment of
LVFWR have been of several types and include the bio-
logic glues (fibrin based or gelatin hydrogels) as well as the
synthetic cyanoacrylate monomers. Fibrin glues function
by reproducing the normal clotting cascade and result in a
stable fibrin matrix after the degradation of exogenous
fibrinogen. The main advantage is their lack of toxicity and
complete biocompatibility.42 Gelatin-based glues have
greater bonding strength than fibrin glues; however, cyto-
toxic effect has been shown, due to the release of formalde-
hyde during degradation, raising concerns regarding
potential long-term complications.43 The main limitation of
both these biologic glues is that they are effective only in
the absence of bleeding. Synthetic glues, such as cyanoacr-
ylate, are monomers that polymerize in an exothermic reac-
tion when brought into contact with fluid. Although they
are cytotoxic and potentially mutagenic, acetylation has
greatly reduced these concerns.44 Using Histoacryl® to
secure a patch of Teflon® onto the myocardium, Padró and
coworkers reported a 100% survival rate among 13 patients
treated for subacute LVFWR.3
Surgical techniques
As previously mentioned, several different techniques can
be applied to treat post-infarction LVFWR. Depending on
the optional use of sutures to treat the rupture of the ven-
tricular wall, two different kinds of surgical approach can
be proposed: sutureless and sutured repair. Initially, the
sutured techniques were the only ones used. Such
approaches included: i) linear closure, ii) infarctectomy and
closure, and iii) patch covering. More recently, the availa-
bility of tissue adhesive materials and surgical glues have
allowed the wide diffusion of the sutureless technique.
Figure 2.  Pre-operative management.
An algorithm that can be applied in cases of left ventricular free-wall rupture.
AMI: acute myocardial infarction; LVFWR: left ventricular free-wall rupture; IABP: intra-aortic balloon pump.
Matteucci et al.	 383
Principles of surgical treatment of LVFWR are to relieve
tamponade, close the tear and/or stop the bleeding, anchor
the repair on healthy tissue and minimize distortion of heart
geometry, while preventing recurrence of rupture or pseu-
doaneurysm formation. The chosen method for surgical
repair is usually dictated by the type of rupture, its sur-
rounding tissues and the presence of concomitant lesions.
Linear closure
The first successful repairs of LVFWR with linear closure
were reported by Montegut10 and Cobbs and colleagues.45
In this technique, the ventricular tear is closed with
Prolene® horizontal mattress sutures buttressed by Teflon®
felt. The sutures should be along the non-ischaemic area to
avoid suture in the necrotic myocardium, which usually
generates myocardial tearing and increased bleeding.
Additionally, an over and over suture can be taken, approxi-
mating the edges of the Teflon® felts, to achieve a satisfac-
tory haemostasis45 (Figure 4). Better results have been
reported using linear closure between strips of Teflon® felt,
if the ventricular tear and surrounding infarct area are cov-
ered with a patch secured to the heart surface with stitches,
sutures or surgical glue.
This technique is usually not feasible in the presence of
a large necrotic area, based on the potential distortion and
excessive reduction of the residual left ventricular cavity.
Figure 3.  Post-operative management.
General principles of post-operative care after left ventricular free-wall rupture repair.
LVFW: left ventricular free-wall; ICU: intensive care unit; IABP: intra-aortic balloon pump.
Figure 4.  Linear closure.
The ventricular tear is closed with Prolene® horizontal mattress
sutures with two supporting Teflon® felt; an over and over suture is
taken to achieve haemostasis.
384	 European Heart Journal: Acute Cardiovascular Care 8(4)
Infarctectomy and closure
Infarct excision and closure of the defect, with either direct
closure or prosthetic patch, has fallen into disuse as a result
of the increased application of biological glues. These pro-
cedures are possibly now reserved for the treatment of
acute massive ruptures (blow-out type rupture) or in the
presence of concomitant lesions such as a post-infarction
ventricular septal defect.
In the conventional approach, the excision of necrotic
myocardial tissue is followed by replacement using a pros-
thetic patch, carefully fashioned to reestablish the geometry
of the left ventricular chamber17 (Figure 5), or by direct clo-
sure of the myocardial defect with interrupted mattress
sutures reinforced with Teflon® felt.46 As described by
Reardon et al., once the prosthetic patch is sutured with
pledgeted interrupted sutures, the edge can be oversewn to
the myocardium with a continuous Prolene® running suture
to achieve haemostasis.17
Such surgical techniques are demanding. Transmural
stitches are placed in a healthy but friable myocardial tis-
sue, so a tear could occur, and the suture line, placed along
the non-ischaemic myocardium, can lead to heart geome-
try distortion and further deterioration of ventricular func-
tion, due to new iatrogenic myocardial infarction areas.
Furthermore, heparinization associated with CPB increases
the risk of bleeding.
Patch covering
Some authors considered this technique the method of
choice when LVFWR shows no active bleeding (or direct
tear).47 In this method, ventricular rupture and the sur-
rounding infarcted muscle are covered with a patch grafted
to the healthy epicardium by Prolene® running sutures
(Figure 6). Meticulous attention should be paid to avoiding
coronary involvement. Glue, injected underneath the patch,
is a mandatory adjunct to increase the compression strength
on the myocardium and prevent blood leakage to the epi-
cardial surface along the suture line.28,29
Because the anchoring sutures are placed only in the epi-
cardium, myocardial damage is minimal. Furthermore, in
active bleeding cardiac ruptures, fixing the patch with run-
ning sutures appears to be more effective to prevent re-rup-
ture than a sutureless technique. Although this type of repair
can be performed avoiding CPB, some surgeons prefer to
perform it on CPB with aortic cross clamp to reduce the ten-
sion on the epicardial tissue and cardiac movement, thereby
favouring a quicker and more effective running suture and
reducing the risk of further myocardial tearing.48
Figure 5.  Infarctectomy and closure of the defect with a
prosthetic patch.
After infarctectomy, a prosthetic patch is fashioned to fit this space and
is sutured with pledgeted interrupted sutures.
Figure 6.  Patch covering technique.
A patch of pericardium is sealed on the infarcted area using surgical glue
and fixed with a running Prolene® suture on the surrounding healthy
myocardium.
Matteucci et al.	 385
Pocar and colleagues reported a modified patch cover-
ing technique in which a Tachosil® fleece was applied to
widely cover the ventricular tear and the adjacent infarcted
tissue; thereafter, a generous pericardial patch was fixed
with a few separate Prolene® stitches and fibrin glue was
injected to seal the two layers.40
Sutureless repair
Availability of tissue adhesive materials has allowed a
sutureless patch technique of repair for the oozing type of
ventricular rupture. A prosthetic patch, adequately fash-
ioned to cover the area of haematoma and muscle necrosis,
its borders placed on healthy myocardium in the peri-
necrotic area, is fixed onto the myocardial surface with sur-
gical glue. The glued patch must be held in place for 1 to 3
min (depending on the type of glue used), until it becomes
firmly adherent and haemostatic. As reported above, a wide
range of synthetic and biological glues can be used for this
purpose. The obvious limitation of the biological glues is
that they are effective only in the absence of active bleed-
ing. So glues should preferably be used if the tear is sealed
or the lesion is of the oozing type.
Lachapelle et al. suggested that even patients with
actively bleeding lesions can be treated using sutureless
repair, provided they are on CPB with total decompression
of the heart.49 Nevertheless, concerns remain over the
safety of this technique when applied to treat blow-out rup-
tures. In this setting, the risk of recurrent re-rupture and
pseudoaneurysm formation is high, since it is very unlikely
that a simply glued patch can withstand the intraventricular
pressure when there is a direct communication between the
left ventricular cavity and pericardial space.
Recent reports are likely to shift toward the use of colla-
gen sponge patch (Figure 7). A TachoComb® or Tachosil®
patch is placed and pressed with wet gauze to the dry surface
of the ventricle for a few minutes. When a simple patch is not
large enough to cover the entire damage surface, a second
patch is applied. Again, surrounding healthy myocardium
not involved in the necrotic process is important to allow bet-
ter anchoring and avoid re-rupture. This surgical approach,
particularly when reserved to treat patients with oozing type
rupture, has shown satisfactory clinical results.50,51
In conclusion, the sutureless technique is simple, fast
and can be done without CPB; moreover, it preserves left
ventricular geometry and, leaving the necrotic tissue
untouched, provides complete haemostasis. However,
before considering this approach to be safe and suitable for
all types of LVFWR, further investigations are required.
Percutaneous intra-pericardial
fibrin-glue injection therapy
Recently, a new therapeutic option, namely percutaneous
intra-pericardial fibrin-glue injection therapy (PIFIT), has
been introduced to the clinical setting. The use of PIFIT to
enhance haemostasis in post-infarction LVFWR was first
described by Ogiwara et al. in 1995.52 Fibrin-glue, compris-
ing fibrinogen and thrombin, when topically applied, exerts
a local haemostatic and sealant effect. It is widely used in
various surgical procedures.53 PITIF for LVFWR was
reported in several case reports with reasonable short- and
medium-term clinical outcomes.54,55 The use of intra-peri-
cardial thrombin injection, as an alternative sealant, has also
been reported.56 Despite an initial concern about uncon-
trolled pericardial adhesion after fibrin-glue application,
reports, using serial echocardiographic follow-up, have not
shown development of left ventricular restriction.54
However, Terashima et al. reported an in-hospital mortality
of 25%,54 thereby, at present, such a technique should be
applied only to patients with LVFWR and high surgical risk
due to poor general condition.
Conservative management
Conservative management, in patients with sub-acute
LVFWR who have recovered from cardiac tamponade
(with or without pericardiocentesis) and have a prohibitive
surgical risk, or when emergency surgical repair is not
available, has been described. Management includes main-
tenance of fluid infusion and inotropic support as needed,
with early attempts at weaning within the ensuing 24 h.
Figure 7.  Sutureless repair.
A TachoSil® patch is applied to widely cover the ventricular wall
rupture and the adjacent infarcted tissues.
386	 European Heart Journal: Acute Cardiovascular Care 8(4)
This is followed by institution of beta-blockade therapy and
strict blood pressure control. Insertion of IABP, reducing
left ventricular wall stress and intra-cavitary pressure,
could limit infarct extension and avoid re-rupture.
Prolonged bed rest has also been included in the conserva-
tive management to prevent arterial hypertension or hyper-
tensive crisis, often considered the precipitating causes of
re-rupture.57 Subjects who survive generally have small
leaks that might close spontaneously by epicardial fibrin
deposits. Obviously, this kind of treatment should be con-
sidered as unusual and non-standard. Blinc et al. conducted
a retrospective cohort study of 107 patients who developed
LVFWR; survival for the conservatively treated group was
only 10%.58 By contrast, surgically treated patients had
acceptable long-term survival (50%). So, surgical repair
has to be considered undoubtedly the treatment of choice.
Conclusion
Despite the first successful LVFWR repair dating back to
the year 1972, this surgical procedure continues to be asso-
ciated with high in-hospital mortality rates.6
Different techniques have been developed over the years
for the management of LVFWR. Nevertheless, the optimal
surgical treatment for this post-AMI mechanical complica-
tion remains controversial. Although the technical strategy
varies, a basic principle that appears to remain unchanged
is that surgeons should put the stitches, or fixed patches, in
the healthy myocardial tissue.
To date, sutured techniques should be considered the proce-
dure of choice for surgical repair of LVFWR with active bleed-
ing at the site of rupture. In the presence of oozing rupture, the
most common operative finding, the sutureless technique rep-
resents a safe and effective alternative option, demonstrating
satisfactory outcome results. This field still has room for car-
diac surgeons to improve surgical strategies and techniques.
Conflict of interest
RL is the Principal Investigator of PERSIST-AVR Trial sponsored
by LivaNova and he is consultant for Medtronic.
Funding
This research received no specific grant from any funding agency
in the public, commercial, or not-for-profit sectors.
References
	 1.	 Nishiyama K, Okino S, Andou J, et al. Coronary angioplasty
reduces free wall rupture and improves mortality and mor-
bidity of acute myocardial infarction. J Invasive Cardiol
2004; 16: 554–548.
	 2.	 Qian G, Wu C, Chen YD, et al. Predictive factors of cardiac
rupture in patients with ST-elevation myocardial infarction.
J Zhejiang Univ Sci B 2014; 15: 1048–1054.
	 3.	 Padró JM, Mesa JM, Silvestre J, et al. Subacute cardiac rup-
ture: Repair with a sutureless technique. Ann Thorac Surg
1993; 55: 20–23.
	 4.	 Nasir A, Gouda M, Khan A, et al. Is it ever possible to treat
left ventricular free wall rupture conservatively? Interact
Cardiovasc Thorac Surg 2014; 19: 488–493.
	 5.	 Terashima M, Fujiwara S, Yaginuma GY, et al. Outcome of
percutaneous intrapericardial fibrin-glue injection therapy
for left ventricular free wall rupture secondary to acute myo-
cardial infarction. Am J Cardiol 2008; 101: 419–421.
	 6.	 Formica F, Mariani S, Singh G, et al. Postinfarction left ven-
tricular free wall rupture: A 17-year single-centre experience.
Eur J Cardiothorac Surg 2018; 53: 150–156.
	7.	 Sakaguchi G, Komiya T, Tamura N, et al. Surgical treat-
ment for postinfarction left ventricular free wall rupture. Ann
Thorac Surg 2008; 85: 1344–1346.
	8.	 Harvey W. Complete works. Willis R (transl.) London:
Sydenham Society, 1647, p.127.
	 9.	 Morgagni JB. The seat and causes of disease investigated by
anatomy, vol. 1. Alexander B (transl.). London: Millar A and
Caddel T, 1769, pp.811–834.
	10.	 Montegut FJ Jr. Left ventricular rupture secondary to myo-
cardial infarction. Report of survival with surgical repair.
Ann Thorac Surg 1972; 14: 75–78.
	11.	 Krumbhaar EB and Crowell C. Spontaneous rupture of the
heart. Am J Med Sci 1925; 170: 828.
	12.	 Hatcher CR Jr, Mansour K, Logan WD Jr, et al. Surgical
complications of myocardial infarction. Am Surg 1970; 36:
163–170.
	13.	 FitzGibbon GM, Hooper GD and Heggtveit HA. Successful
surgical treatment of postinfarction external cardiac rupture.
J Thorac Cardiovasc Surg 1972; 63: 622–630.
	14.	 Calick A, Kerth W, Barbour D, et al. Successful surgical
therapy of ruptured myocardium. Chest 1974; 66: 188.
	15.	 Núñez L, de la Llana R, López Sendón J, et al. Diagnosis
and treatment of subacute free wall ventricular rupture after
infarction. Ann Thorac Surg 1983; 35: 525–529.
	16.	 Löfström B, Mogensen L, Nyquist O, et al. 3. Attempts at
emergency surgical treatment. Chest 1972; 61: 10–13.
	17.	 Reardon MJ, Carr CL, Diamond A, et al. Ischemic left ven-
tricular free wall rupture: Prediction, diagnosis, and treat-
ment. Ann Thorac Surg 1997; 64: 1509–1513.
	18.	 Pohjola-Sintonen S, Muller JE, Stone PH, et al. Ventricular
septal and free wall rupture complicating acute myocardial
infarction: Experience in the Multicenter Investigation of
Limitation of Infarct Size. Am Heart J 1989; 117: 809–818.
	19.	 French JK, Hellkamp AS, Armstrong PW, et al. Mechanical
complications after percutaneous coronary intervention in
ST-elevation myocardial infarction (from APEX-AMI). Am
J Cardiol 2010; 105: 59–63.
	20.	 Lancellotti P, Price S, Edvardsen T, et al. The use of echocar-
diography in acute cardiovascular care: Recommendations
of the European Association of Cardiovascular Imaging and
the Acute Cardiovascular Care Association. Eur Heart J
Acute Cardiovasc Care 2015; 4: 3–5.
	21.	 Porto AG, McAlindon E, Ascione R, et al. Magnetic reso-
nance imaging-based management of silent cardiac rupture.
J Thorac Cardiovasc Surg 2015; 149: e31–e33.
	22.	 Villanueva C, Milder D and Manganas C. Ruptured left
ventricular false aneurysm following acute myocardial
infarction: Case report and review of the literature. Heart
Lung Circ 2014; 23: e261–263.
	23.	 Frances C, Romero A and Grady D. Left ventricular pseu-
doaneurysm. J Am Coll Cardiol 1998; 32: 557–561.
Matteucci et al.	 387
	24.	 Roelandt JR, Sutherland GR, Yoshida K, et al. Improved
diagnosis and characterization of left ventricular pseudoa-
neurysm by Doppler color flow imaging. J Am Coll Cardiol
1988; 12: 807–811.
	25.	 Orsborne C and Schmitt M. Left ventricular pseudoaneu-
rysm after myocardial infarction detected by cardiac MRI.
BMJ Case Rep 2014; 2014: bcr2014207277.
	26.	 Lazzeri C, Bernardo P, Sori A, et al. Venous-arterial extracor-
poreal membrane oxygenation for refractory cardiac arrest:A
clinical challenge. Eur Heart J Acute Cardiovasc Care 2013;
2: 118–126.
	27.	 Sutherland FW, Guell FJ, Pathi VL, et al. Postinfarction ven-
tricular free wall rupture: Strategies for diagnosis and treat-
ment. Ann Thorac Surg 1996; 61: 1281–1285.
	28.	 Iemura J, Oku H, Otaki M, et al. Surgical strategy for left
ventricular free wall rupture after acute myocardial infarc-
tion. Ann Thorac Surg 2001; 71: 201–204.
	29.	 Mantovani V, Vanoli D, Chelazzi P, et al. Post-infarction car-
diac rupture: Surgical treatment. Eur J Cardiothorac Surg
2002; 22: 777–780.
	30.	 Leva C, Bruno PG, Gallorini C, et al. Complete myocardial
revascularization and sutureless technique for left ventricu-
lar free wall rupture: Clinical and echocardiographic results.
Interact Cardiovasc Thorac Surg 2006; 5: 408–412.
	31.	 Okada K, Yamashita T, Matsumori M, et al. Surgical treatment
for rupture of left ventricular free wall after acute myocardial
infarction. Interact Cardiovasc Thorac Surg 2005; 4: 203–206.
	32.	Timóteo AT, Nogueira MA, Rosa SA, et al.; ProACS
Investigators. Role of intra-aortic balloon pump counterpulsa-
tion in the treatment of acute myocardial infarction complicated
by cardiogenic shock: Evidence from the Portuguese nationwide
registry. Eur Heart J Acute Cardiovasc Care 2016; 5: 23–31.
	33.	 Sousa-Uva M, Neumann FJ, Ahlsson A, et al.; ESC Scientific
Document Group. 2018 ESC/EACTS Guidelines on myocar-
dial revascularization. Eur J Cardiothorac Surg 2019; 55: 4–90.
	34.	 Canovas SJ, Lim E, Dalmau MJ, et al. Midterm clinical and
echocardiographic results with patch glue repair of left ven-
tricular free wall rupture. Circulation 2003; 108(Suppl. 1):
II237–II240.
	35.	 Zeebregts CJ, Noyez L, Hensens AG, et al. Surgical repair of
subacute left ventricular free wall rupture. J Card Surg 1997;
12: 416–419.
	36.	 Prêtre R, Benedikt P and Turina MI. Experience with postin-
farction left ventricular free wall rupture. Ann Thorac Surg
2000; 69: 1342–1345.
	37.	 Simo KA, Hanna EM, Imagawa DK, et al. Hemostatic agents
in hepatobiliary and pancreas surgery: A review of the litera-
ture and critical evaluation of a novel carrier-bound fibrin
sealant (TachoSil). ISRN Surg 2012; 2012: 729086.
	38.	 Fuglsang K, Dueholm M, Stæhr-Hansen E, et al. Uterine
healing after therapeutic intrauterine administration of
TachoSil (hemostatic fleece) in cesarean section with post-
partum hemorrhage caused by placenta previa. J Pregnancy
2012; 2012: 635683.
	39.	 Maisano F, Kjaergård HK, Bauernschmitt R, et al. TachoSil
surgical patch versus conventional haemostatic fleece material
for control of bleeding in cardiovascular surgery:Arandomised
controlled trial. Eur J Cardiothorac Surg 2009; 36: 708–714.
	40.	 Pocar M, Passolunghi D, BregasiA, et al. TachoSil for postin-
farction ventricular free wall rupture. Interact Cardiovasc
Thorac Surg 2012; 14: 866–867.
	41.	 Muto A, Nishibe T, Kondo Y, et al. Sutureless repair with
TachoComb sheets for oozing type postinfarction cardiac
rupture. Ann Thorac Surg 2005; 79: 2143–2145.
	42.	 Byrne DJ, Hardy J, Wood RA, et al. Effect of fibrin glues
on the mechanical properties of healing wounds. Br J Surg
1991; 78: 841–843.
	43.	 Bingley JA, Gardner MA, Stafford EG, et al. Late complica-
tions of tissue glues in aortic surgery. Ann Thorac Surg 2000;
69: 1764–1768.
	44.	 Kung H. Evaluation of the undesirable side-effects of the
surgical use of histoacryl glue with special regard to pos-
sible carcinogenicity. Basel, Switzerland: RCC Institute for
Contract Research in Toxicology and Ecology, 1986.
	45.	 Cobbs BW Jr, Hatcher CR Jr and Robinson PH. Cardiac rup-
ture. Three operations with two long-term survivals. JAMA
1973; 223: 532–535.
	46.	 Schwarz CD, Punzengruber C, Ng CK, et al. Clinical
presentation of rupture of the left-ventricular free wall
after myocardial infarction: Report of five cases with suc-
cessful surgical repair. Thorac Cardiovasc Surg 1996; 44:
71–75.
	47.	 Coletti G, Torracca L, Zogno M, et al. Surgical management
of left ventricular free wall rupture after acute myocardial
infarction. Cardiovasc Surg 1995; 3: 181–186.
	48.	 Haddadin S, Milano AD, Faggian G, et al. Surgical treatment
of postinfarction left ventricular free wall rupture. J Card
Surg 2009; 24: 624–631.
	49.	 Lachapelle K, deVarennes B, Ergina PL, et al. Sutureless
patch technique for postinfarction left ventricular rupture.
Ann Thorac Surg 2002; 74: 96–101
	50.	 Raffa GM, Tarelli G, Patrini D, et al. Sutureless repair for
postinfarction cardiac rupture: A simple approach with a
tissue-adhering patch. J Thorac Cardiovasc Surg 2013; 145:
598–599.
	51.	Bergman R, Jainandunsing JS, Woltersom BD, et al.
Sutureless management of left ventricle wall rupture; a series
of three cases. J Cardiothorac Surg 2014; 9: 136.
	52.	 Ogiwara M, Kyo S, Yokote Y, et al. [Clinical result of left
ventricular free wall rupture resulting from acute myocardial
infarction]. Kyobu Geka 1995; 48: 286–289.
	53.	 Spotnitz WD. Fibrin sealant: Past, present, and future: A
brief review. World J Surg 2010; 34: 632–634.
	54.	 Terashima M, Fujiwara S, Yaginuma GY, et al. Outcome of
percutaneous intrapericardial fibrin-glue injection therapy
for left ventricular free wall rupture secondary to acute myo-
cardial infarction. Am J Cardiol 2008; 101: 419–421.
	55.	 Joho S, Asanoi H, Sakabe M, et al. Long-term usefulness
of percutaneous intrapericardial fibrin-glue fixation therapy
for oozing type of left ventricular free wall rupture: A case
report. Circ J 2002; 66: 705–706.
	56.	 Lee JK, Tsui KL, Chan KK, et al. Intra-pericardial thrombin
injection for post-infarction left ventricular free wall rupture.
Eur Heart J Acute Cardiovasc Care 2012; 1: 337–340.
	57.	 Figueras J, Cortadellas J, Evangelista A, et al. Medical
management of selected patients with left ventricular free
wall rupture during acute myocardial infarction. J Am Coll
Cardiol 1997; 29: 512–518.
	58.	 Blinc A, Noc M, Pohar B, et al. Subacute rupture of the left
ventricular free wall after acute myocardial infarction. Three
cases of long-term survival without emergency surgical
repair. Chest 1996; 109: 565–567.

Contenu connexe

Tendances

LANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADLANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADPraveen Nagula
 
CALCIFIED CORONARY ARTERY LESIONS.pptx
CALCIFIED CORONARY ARTERY LESIONS.pptxCALCIFIED CORONARY ARTERY LESIONS.pptx
CALCIFIED CORONARY ARTERY LESIONS.pptxAbhishek Sakwariya
 
Role of beta blockers in the management of cardiovascular diseases
Role of beta blockers in the management of cardiovascular diseasesRole of beta blockers in the management of cardiovascular diseases
Role of beta blockers in the management of cardiovascular diseasesPHAM HUU THAI
 
PCI complications
PCI complicationsPCI complications
PCI complicationsIqbal Dar
 
Redo cardiac surgery in adults
Redo cardiac surgery in adultsRedo cardiac surgery in adults
Redo cardiac surgery in adultsSpringer
 
Vascular access in cardiac catheterization
Vascular access in cardiac catheterizationVascular access in cardiac catheterization
Vascular access in cardiac catheterizationRamachandra Barik
 
fractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSIC
fractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSICfractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSIC
fractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSICPROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)Raghu Kishore Galla
 
Ischemia trial
Ischemia trialIschemia trial
Ischemia trialDrvasanthi
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomographyBHAWANI SHANKAR
 
Devices and technology in interventional cardiology
Devices and technology in interventional cardiologyDevices and technology in interventional cardiology
Devices and technology in interventional cardiologyRamachandra Barik
 

Tendances (20)

LANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADLANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CAD
 
Coronary stent thrombosis
Coronary stent thrombosisCoronary stent thrombosis
Coronary stent thrombosis
 
Ffr
FfrFfr
Ffr
 
CALCIFIED CORONARY ARTERY LESIONS.pptx
CALCIFIED CORONARY ARTERY LESIONS.pptxCALCIFIED CORONARY ARTERY LESIONS.pptx
CALCIFIED CORONARY ARTERY LESIONS.pptx
 
Fraction flow reserve
Fraction flow reserveFraction flow reserve
Fraction flow reserve
 
Management of Small Aortic Root
Management of Small Aortic RootManagement of Small Aortic Root
Management of Small Aortic Root
 
Role of beta blockers in the management of cardiovascular diseases
Role of beta blockers in the management of cardiovascular diseasesRole of beta blockers in the management of cardiovascular diseases
Role of beta blockers in the management of cardiovascular diseases
 
PCI complications
PCI complicationsPCI complications
PCI complications
 
Redo cardiac surgery in adults
Redo cardiac surgery in adultsRedo cardiac surgery in adults
Redo cardiac surgery in adults
 
Mitral valve repair
Mitral valve repairMitral valve repair
Mitral valve repair
 
Vascular access in cardiac catheterization
Vascular access in cardiac catheterizationVascular access in cardiac catheterization
Vascular access in cardiac catheterization
 
fractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSIC
fractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSICfractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSIC
fractional flow reserve FFR dr md toufiqur rahman FSCAI FAHA FAPSIC
 
Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)
 
Bifurcation stenting
Bifurcation stentingBifurcation stenting
Bifurcation stenting
 
Ischemia trial
Ischemia trialIschemia trial
Ischemia trial
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
 
Trans septal puncture
Trans septal punctureTrans septal puncture
Trans septal puncture
 
The story of coronary stent
The story of coronary stentThe story of coronary stent
The story of coronary stent
 
Devices and technology in interventional cardiology
Devices and technology in interventional cardiologyDevices and technology in interventional cardiology
Devices and technology in interventional cardiology
 

Similaire à Post infarction left ventricular free-wall rupture

Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...
Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...
Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...M A Hasnat
 
Case report cardivascj20136(1)68 70
Case report cardivascj20136(1)68 70Case report cardivascj20136(1)68 70
Case report cardivascj20136(1)68 70DrMAHasnat
 
Vertebral artery injury with dialysis catheter
Vertebral artery injury with dialysis catheterVertebral artery injury with dialysis catheter
Vertebral artery injury with dialysis catheterMuhammad Asim Rana
 
Acs0609 Surgical Treatment Of Carotid Artery Disease
Acs0609 Surgical Treatment Of Carotid Artery DiseaseAcs0609 Surgical Treatment Of Carotid Artery Disease
Acs0609 Surgical Treatment Of Carotid Artery Diseasemedbookonline
 
Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...
Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...
Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...asclepiuspdfs
 
Coronary artery perforation complicating percutaneous coronary intervention
Coronary artery perforation complicating percutaneous coronary interventionCoronary artery perforation complicating percutaneous coronary intervention
Coronary artery perforation complicating percutaneous coronary interventionAbdulsalam Taha
 
Venus obstructive outflow
Venus obstructive outflowVenus obstructive outflow
Venus obstructive outflowifrahjaved
 
Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...
Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...
Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...Abdulsalam Taha
 
Therapeutic myocardial infarction
Therapeutic myocardial infarctionTherapeutic myocardial infarction
Therapeutic myocardial infarctionRamachandra Barik
 
ESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptx
ESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptxESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptx
ESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptxBedahVaskular
 
PA CATHETER (1).pptx
PA CATHETER (1).pptxPA CATHETER (1).pptx
PA CATHETER (1).pptxCutiePie71
 
Management of left ventricular aneurysm
Management of left ventricular aneurysmManagement of left ventricular aneurysm
Management of left ventricular aneurysmAbdulsalam Taha
 
Perioperative cardiac assesment and interventions
Perioperative cardiac  assesment and interventionsPerioperative cardiac  assesment and interventions
Perioperative cardiac assesment and interventionsNAJEEB ULLAH SOFI
 
Cardiac imaging in prosthetic paravalvular leaks
Cardiac imaging in prosthetic paravalvular leaksCardiac imaging in prosthetic paravalvular leaks
Cardiac imaging in prosthetic paravalvular leaksPaul Schoenhagen
 
1 s2.0-s0140673616005584-main
1 s2.0-s0140673616005584-main1 s2.0-s0140673616005584-main
1 s2.0-s0140673616005584-maingisa_legal
 

Similaire à Post infarction left ventricular free-wall rupture (20)

Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...
Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...
Percutaneous Transvenous Mitral Commissurotomy in 71 Years Old Woman with Mit...
 
Case report cardivascj20136(1)68 70
Case report cardivascj20136(1)68 70Case report cardivascj20136(1)68 70
Case report cardivascj20136(1)68 70
 
Bifurcation stenting
Bifurcation stentingBifurcation stenting
Bifurcation stenting
 
Vertebral artery injury with dialysis catheter
Vertebral artery injury with dialysis catheterVertebral artery injury with dialysis catheter
Vertebral artery injury with dialysis catheter
 
Acs0609 Surgical Treatment Of Carotid Artery Disease
Acs0609 Surgical Treatment Of Carotid Artery DiseaseAcs0609 Surgical Treatment Of Carotid Artery Disease
Acs0609 Surgical Treatment Of Carotid Artery Disease
 
Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...
Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...
Contemporary Perspectives on the Diagnosis and Management of Hypertrophic Car...
 
Coronary artery perforation complicating percutaneous coronary intervention
Coronary artery perforation complicating percutaneous coronary interventionCoronary artery perforation complicating percutaneous coronary intervention
Coronary artery perforation complicating percutaneous coronary intervention
 
Hybrid coranary revascularization
Hybrid  coranary revascularizationHybrid  coranary revascularization
Hybrid coranary revascularization
 
Venus obstructive outflow
Venus obstructive outflowVenus obstructive outflow
Venus obstructive outflow
 
Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...
Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...
Coronary endarterectomy and patch angioplasty for diffuse coronary artery dis...
 
Therapeutic myocardial infarction
Therapeutic myocardial infarctionTherapeutic myocardial infarction
Therapeutic myocardial infarction
 
ESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptx
ESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptxESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptx
ESVS Guidelines ALI 2020 - MARGA compressed [Repaired].pptx
 
Transcatheter therapy for mitral regurgitation
Transcatheter therapy for mitral regurgitationTranscatheter therapy for mitral regurgitation
Transcatheter therapy for mitral regurgitation
 
09 hashem et al
09 hashem et al09 hashem et al
09 hashem et al
 
PA CATHETER (1).pptx
PA CATHETER (1).pptxPA CATHETER (1).pptx
PA CATHETER (1).pptx
 
Management of left ventricular aneurysm
Management of left ventricular aneurysmManagement of left ventricular aneurysm
Management of left ventricular aneurysm
 
Perioperative cardiac assesment and interventions
Perioperative cardiac  assesment and interventionsPerioperative cardiac  assesment and interventions
Perioperative cardiac assesment and interventions
 
Cardiac imaging in prosthetic paravalvular leaks
Cardiac imaging in prosthetic paravalvular leaksCardiac imaging in prosthetic paravalvular leaks
Cardiac imaging in prosthetic paravalvular leaks
 
Cardiac imaging in prosthetic paravalvular leaks
Cardiac imaging in prosthetic paravalvular leaksCardiac imaging in prosthetic paravalvular leaks
Cardiac imaging in prosthetic paravalvular leaks
 
1 s2.0-s0140673616005584-main
1 s2.0-s0140673616005584-main1 s2.0-s0140673616005584-main
1 s2.0-s0140673616005584-main
 

Plus de Ramachandra Barik

Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxRamachandra Barik
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptxRamachandra Barik
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfRamachandra Barik
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyRamachandra Barik
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...Ramachandra Barik
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Ramachandra Barik
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyRamachandra Barik
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomographyRamachandra Barik
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human developmentRamachandra Barik
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendonsRamachandra Barik
 

Plus de Ramachandra Barik (20)

Willens's syndrome.pptx
Willens's syndrome.pptxWillens's syndrome.pptx
Willens's syndrome.pptx
 
Intensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptxIntensive care of congenital heart disease.pptx
Intensive care of congenital heart disease.pptx
 
Management of Hypetension.pptx
Management of Hypetension.pptxManagement of Hypetension.pptx
Management of Hypetension.pptx
 
CRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdfCRISPR and cardiovascular diseases.pdf
CRISPR and cardiovascular diseases.pdf
 
Pacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After SplenectomyPacemaker Pocket Infection After Splenectomy
Pacemaker Pocket Infection After Splenectomy
 
Piccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdfPiccolo Duct Occluder.pdf
Piccolo Duct Occluder.pdf
 
MISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptxMISPLACED ECG LEADS.pptx
MISPLACED ECG LEADS.pptx
 
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...
 
Arrythmia-IV.pptx
Arrythmia-IV.pptxArrythmia-IV.pptx
Arrythmia-IV.pptx
 
Arrythmia-III.pptx
Arrythmia-III.pptxArrythmia-III.pptx
Arrythmia-III.pptx
 
Arrythmia-II.pptx
Arrythmia-II.pptxArrythmia-II.pptx
Arrythmia-II.pptx
 
Arrythmia-I.pptx
Arrythmia-I.pptxArrythmia-I.pptx
Arrythmia-I.pptx
 
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...
 
Anticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancyAnticoagulation therapy during pregnancy
Anticoagulation therapy during pregnancy
 
Coronary guidewire
Coronary guidewireCoronary guidewire
Coronary guidewire
 
Intracoronary optical coherence tomography
Intracoronary optical coherence tomographyIntracoronary optical coherence tomography
Intracoronary optical coherence tomography
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
A roadmap for the human development
A roadmap for the human developmentA roadmap for the human development
A roadmap for the human development
 
Intra aortic balloon pump
Intra aortic balloon pumpIntra aortic balloon pump
Intra aortic balloon pump
 
Left ventricular false tendons
Left ventricular false tendonsLeft ventricular false tendons
Left ventricular false tendons
 

Dernier

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 

Dernier (20)

Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 

Post infarction left ventricular free-wall rupture

  • 1. https://doi.org/10.1177/2048872619840876 European Heart Journal: Acute Cardiovascular Care 2019, Vol. 8(4) 379­–387 © The European Society of Cardiology 2019 Article reuse guidelines: sagepub.com/journals-permissions DOI: 10.1177/2048872619840876 journals.sagepub.com/home/acc Introduction Left ventricular free-wall rupture (LVFWR) may represent a dramatic and life-threatening event, occurring in up to 2% of patients with acute myocardial infarction (AMI).1,2 The clinical presentation varies from a catastrophic blowout type characterized by cardiogenic shock and eventually cardiac arrest, to the oozing type with haemodynamic insta- bility and pericardial effusion.3 Prompt diagnosis and management can lead to success- ful treatment for LVFWR. Conservative strategies have been described,4,5 but the poor results of this treatment make surgical intervention generally mandatory. Despite different surgical approaches having been proposed, in- hospital mortality continues to be high6,7 and the most appropriate surgical management remains still controver- sial, particularly in terms of rupture recurrence or other type of post-operative complications. This review describes the approaches reported in the lit- erature regarding the management of this mechanical com- plication of AMI. Treatment strategies for post-infarction left ventricular free-wall rupture Matteo Matteucci1,2, Dario Fina3,4, Federica Jiritano1,5, Paolo Meani1,4, W Matthijs Blankesteijn6, Giuseppe Maria Raffa7, Mariusz Kowaleski8, Samuel Heuts1, Cesare Beghi2, Jos Maessen1,9 and Roberto Lorusso1,9 Abstract Left ventricular free-wall rupture is one of the most fatal complications after acute myocardial infarction. Surgical treatment of post-infarction left ventricular free-wall rupture has evolved over time. Direct closure of the ventricular wall defect (linear closure) and resection of the infarcted myocardium (infarctectomy), with subsequent closure of the created defect with a prosthetic patch, represented the original techniques. Recently, less aggressive approaches, either with the use of surgical glues or the application of collagen sponge patches on the infarct area to cover the tear and achieve haemostasis, have been proposed. Despite such modifications in the therapeutic strategy and surgical treatment, however, postoperative in-hospital mortality may be as high as 35%. In extremely high-risk or inoperable patients, a non- surgical approach has been reported. Keywords Cardiac rupture, myocardial infarction, surgical treatment, mechanical complication Date received: 29 January 2019; accepted: 28 February 2019 1Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, The Netherlands 2Department of Cardiac Surgery, Circolo Hospital, University of Insubria, Varese, Italy 3Department of Cardiology, IRCCS Policlinico San Donato, University of Milan, Italy 4Department of Cardiology, Heart and Vascular Centre, Maastricht University Medical Centre, The Netherlands 5Department of Cardiac Surgery, University Magna Graecia of Catanzaro, Italy 6Department of Pharmacology and Toxicology, Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands 7Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy 8Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior in Warsaw, Poland 9Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands Corresponding author: Matteo Matteucci, Cardiothoracic Surgery Department – Heart Vascular Centre, Maastricht University Medical Centre (MUMC), P. Debyelaan, 12 – 6221 AZ, Maastricht, The Netherlands. Email: teo.matte@libero.it 840876ACC European Heart Journal: Acute Cardiovascular CareMatteucci et al. Review
  • 2. 380 European Heart Journal: Acute Cardiovascular Care 8(4) History The first free-wall rupture of the heart after AMI was described by William Harvey in 1647.8 In 1769, Morgagni collected and reported 11 cases of myocardial rupture dis- covered postmortem9 (Figure 1). Ironically, Morgagni him- self later died of ventricular rupture. Duaine, in 1871, reported the first large series of patients with cardiac rup- ture and concluded that rupture never occurs spontane- ously.10 However, it was not until 1925, in the report of Krumbhaar and Crowell, that the relationship of LVFWR to myocardial infarction was first pointed out.11 Hatcher and associates, from Emory University, in 1970 described the first successful operation for free-wall rup- ture of the right ventricle.12 Two years later, Fitzgibbon et al. reported the successful repair of LVFWR associated with ischaemic heart disease.13 Cardiac rupture was treated, on cardiopulmonary bypass (CPB), with infarctectomy and closure of the myocardial defect. In the same year, Montegut described the history of a 58-year-old man who was suc- cessfully treated for post-infarction LVFWR with direct suture.10 In 1973, Calick et al. reported the surgical repair of rup- tured myocardium with a Dacron® patch placed over the area of perforation.14 Ten years later, Nunez and colleagues described post-AMI free-wall ventricular rupture in seven patients who underwent surgical intervention.15 The control of haemorrhage was obtained by covering the ventricular tear and the surrounding infarcted myocardium with a Teflon® patch fixed on epicardium by a continuous Prolene® suture.15 The first attempt to repair LVFWR with a patch fixed with glue over the area of rupture was reported by Löfström and associates in 1972, but the Dacron® patch loosened soon after the operation, causing the patient’s death.16 In 1993, the first series of patients successfully treated with a Figure 1.  Morgagni’s description of a case of ventricular wall rupture. Frontispiece of De sedibus, et causis morborum per anatomen indagatis (JB Morgagni, 1765), with a portrait of Morgagni and Morgagni’s description (‘Epistola anatomico-medica XXVII’) of a case of ventricular wall rupture (by courtesy of the Medical Library of Spedali Civili, Brescia, Italy).
  • 3. Matteucci et al. 381 sutureless epicardial patch technique was described.3 Padró and colleagues successfully treated 13 patients with suba- cute LVFWR using a Teflon® patch fixed onto the heart surface with only surgical glue.3 Operative strategies Clinical presentation and course are variable, depending on the location, the size and the time-course of the rupture.17 Although acute LVFWR is often fatal, some patients with subacute or contained rupture present with a window of opportunity for intervention.18,19 Thereby, the diagnosis or even a high suspicion of cardiac rupture represents an indi- cation for emergency surgery without further delay. The most important diagnostic method for LVFWR is transthoracic echocardiography: the presence of reduced myocardial wall thickness, haemopericardium or epicardial clots and cardiac tamponade are the most relevant findings.20 In suitable patients, cardiac magnetic resonance can complement the diagnosis by identifying contained ventricular rupture.21 Pericardiocentesis prior to surgery, which confirms a haemorrhagic effusion, may further sup- port the diagnosis, but the definitive diagnosis is usually made at surgery. Rarely, the rupture of the free-wall of the left ventricle is contained by epicardial clots or pericardial adhesions, lead- ing to the formation of a pseudoaneurysm. Left ventricular pseudoaneurysm (LVPA) that occurs a few days after AMI may be unstable and tends to rupture.22 Since the clinical presentation of this condition is variable, ranging from une- ventful condition to congestive heart failure, or even sud- den death,23 a high index of suspicion for this serious complication of AMI is paramount. Diagnosis can be made by several imaging techniques, including echocardiogra- phy, computed tomography, ventriculography and mag- netic resonance imaging (MRI). Echocardiography is the first-line imaging modality in suspected LVPA. Colour- Doppler can help to demonstrate the discontinuity of the ventricular wall and highlight the distinctive bi-directional flow between the extracardiac echo-free space and the left ventricle.24 Contrast ventriculography has the likelihood of establishing a definitive diagnosis23 and can help along with coronary angiography in surgical planning; however, it is an invasive procedure that might precipitate ventricular rupture. Owing to its ability to visualize the heart in precise detail, MRI can provide essential information to confirm diagnosis and clearly elucidate the characteristics of the pseudoaneurysm and guide surgical intervention.25 However, MRI can be performed only in patients with LVPA who remain haemodynamically stable. When the diagnosis of LVPAis established, surgical correction is usu- ally mandatory because onset of rupture is unpredictable. On the way to surgery, restoration of a satisfactory haemodynamic state may require inotropic support, intra- venous fluid, intra-aortic balloon pump (IABP) and peri- cardial drainage, as guided by clinical status (Figure 2). Pericardiocentesis may relieve cardiac tamponade and improve circulation in a critical situation; however, it is often unhelpful because much of the pericardial space is taken up by non-drainable clots. Decompression of the pericardium may also be obtained by subxiphoid drainage or by a classic sternotomy. In the presence of refractory cardiac arrest, extracorporeal membrane oxygenation might provide a chance to perform definitive surgical treatment.26 Different opinions are published about the opportunity to perform coronary angiograms or avoid this investigation in order to ‘save time’.17,27 Some authors believe that coro- nary angiography should be promptly performed as soon as pericardial effusion is noted in AMI patients, before they deteriorate.28,29 The knowledge of coronary status is of great help in deciding where and how to place the sutures during surgery; in addition, a proper revascularization of the diseased vessels supplying the non-infarcted area at the time of LVFWR repair (concomitant coronary artery bypass grafting) has been shown to exert a positive impact on sur- vival and freedom from angina.29,30 Patients being operated for post-AMI LVFWR are gen- erally unstable, so exposure of the femoral vessels at the groin and circuit preparation for rapid institution of CPB should be considered before thoracic incision. The use of CPB support, however, is a matter of controversy. Some authors, in fact, believe that in certain circumstances (anterior defect, haemodynamic stability, oozing type rup- ture, sub-acute course), and with the application of par- ticular surgical techniques (epicardial patch covering, sutureless repair), LVFWR can be safely treated without utilizing CPB.28 The post-operative use of IABP, and other mechanical circulatory support, should always be taken into considera- tion because they can reduce the intra-cavitary pressure of the left ventricle, increase coronary blood flow and limit or prevent the development of low cardiac output syn- drome.17,31 Timóteo and colleagues reported that the use of IABP in patients with post-AMI mechanical complications was associated with improved in-hospital outcome.32 However, the European Society of Cardiology/European Association for Cardio-Thoracic Surgery Guidelines on myocardial revascularization allocate short-term mechani- cal circulatory support, in the presence of post-AMI mechanical complications, in Class of recommendation IIb.33 Further investigations are required to better evaluate the efficacy and safety of mechanical devices in the setting of post-infarction LVFWR repair. General principles of post-operative care, after LVFWR repair, are shown in Figure 3. Surgical materials In the past, surgical treatment of LVFWR was generally achieved using only Prolene® sutures, buttressed or not with Teflon® felt. In recent years, however, cardiac
  • 4. 382 European Heart Journal: Acute Cardiovascular Care 8(4) procedures have employed patches and surgical glues. Different materials have been proposed in patch-based repairs. The most common applied are: Teflon®,15 Goretex®,34 Dacron®35 and pericardium,36 either autolo- gous or xenograft. Collagen sponges, or fleeces, have been utilized in other surgical specialties, ranging from gynae- cology, urology and liver surgery.37,38 The use of collagen sponges in cardiac surgery is not new; its safety has been assessed in different cardio-thoracic procedures.39 However, the indication for using TachoComb® or TachoSil® patches in LVFWR repair has become more common only in recent years, based on preliminary favourable results.40,41 Adhesives reported to be successful in the treatment of LVFWR have been of several types and include the bio- logic glues (fibrin based or gelatin hydrogels) as well as the synthetic cyanoacrylate monomers. Fibrin glues function by reproducing the normal clotting cascade and result in a stable fibrin matrix after the degradation of exogenous fibrinogen. The main advantage is their lack of toxicity and complete biocompatibility.42 Gelatin-based glues have greater bonding strength than fibrin glues; however, cyto- toxic effect has been shown, due to the release of formalde- hyde during degradation, raising concerns regarding potential long-term complications.43 The main limitation of both these biologic glues is that they are effective only in the absence of bleeding. Synthetic glues, such as cyanoacr- ylate, are monomers that polymerize in an exothermic reac- tion when brought into contact with fluid. Although they are cytotoxic and potentially mutagenic, acetylation has greatly reduced these concerns.44 Using Histoacryl® to secure a patch of Teflon® onto the myocardium, Padró and coworkers reported a 100% survival rate among 13 patients treated for subacute LVFWR.3 Surgical techniques As previously mentioned, several different techniques can be applied to treat post-infarction LVFWR. Depending on the optional use of sutures to treat the rupture of the ven- tricular wall, two different kinds of surgical approach can be proposed: sutureless and sutured repair. Initially, the sutured techniques were the only ones used. Such approaches included: i) linear closure, ii) infarctectomy and closure, and iii) patch covering. More recently, the availa- bility of tissue adhesive materials and surgical glues have allowed the wide diffusion of the sutureless technique. Figure 2.  Pre-operative management. An algorithm that can be applied in cases of left ventricular free-wall rupture. AMI: acute myocardial infarction; LVFWR: left ventricular free-wall rupture; IABP: intra-aortic balloon pump.
  • 5. Matteucci et al. 383 Principles of surgical treatment of LVFWR are to relieve tamponade, close the tear and/or stop the bleeding, anchor the repair on healthy tissue and minimize distortion of heart geometry, while preventing recurrence of rupture or pseu- doaneurysm formation. The chosen method for surgical repair is usually dictated by the type of rupture, its sur- rounding tissues and the presence of concomitant lesions. Linear closure The first successful repairs of LVFWR with linear closure were reported by Montegut10 and Cobbs and colleagues.45 In this technique, the ventricular tear is closed with Prolene® horizontal mattress sutures buttressed by Teflon® felt. The sutures should be along the non-ischaemic area to avoid suture in the necrotic myocardium, which usually generates myocardial tearing and increased bleeding. Additionally, an over and over suture can be taken, approxi- mating the edges of the Teflon® felts, to achieve a satisfac- tory haemostasis45 (Figure 4). Better results have been reported using linear closure between strips of Teflon® felt, if the ventricular tear and surrounding infarct area are cov- ered with a patch secured to the heart surface with stitches, sutures or surgical glue. This technique is usually not feasible in the presence of a large necrotic area, based on the potential distortion and excessive reduction of the residual left ventricular cavity. Figure 3.  Post-operative management. General principles of post-operative care after left ventricular free-wall rupture repair. LVFW: left ventricular free-wall; ICU: intensive care unit; IABP: intra-aortic balloon pump. Figure 4.  Linear closure. The ventricular tear is closed with Prolene® horizontal mattress sutures with two supporting Teflon® felt; an over and over suture is taken to achieve haemostasis.
  • 6. 384 European Heart Journal: Acute Cardiovascular Care 8(4) Infarctectomy and closure Infarct excision and closure of the defect, with either direct closure or prosthetic patch, has fallen into disuse as a result of the increased application of biological glues. These pro- cedures are possibly now reserved for the treatment of acute massive ruptures (blow-out type rupture) or in the presence of concomitant lesions such as a post-infarction ventricular septal defect. In the conventional approach, the excision of necrotic myocardial tissue is followed by replacement using a pros- thetic patch, carefully fashioned to reestablish the geometry of the left ventricular chamber17 (Figure 5), or by direct clo- sure of the myocardial defect with interrupted mattress sutures reinforced with Teflon® felt.46 As described by Reardon et al., once the prosthetic patch is sutured with pledgeted interrupted sutures, the edge can be oversewn to the myocardium with a continuous Prolene® running suture to achieve haemostasis.17 Such surgical techniques are demanding. Transmural stitches are placed in a healthy but friable myocardial tis- sue, so a tear could occur, and the suture line, placed along the non-ischaemic myocardium, can lead to heart geome- try distortion and further deterioration of ventricular func- tion, due to new iatrogenic myocardial infarction areas. Furthermore, heparinization associated with CPB increases the risk of bleeding. Patch covering Some authors considered this technique the method of choice when LVFWR shows no active bleeding (or direct tear).47 In this method, ventricular rupture and the sur- rounding infarcted muscle are covered with a patch grafted to the healthy epicardium by Prolene® running sutures (Figure 6). Meticulous attention should be paid to avoiding coronary involvement. Glue, injected underneath the patch, is a mandatory adjunct to increase the compression strength on the myocardium and prevent blood leakage to the epi- cardial surface along the suture line.28,29 Because the anchoring sutures are placed only in the epi- cardium, myocardial damage is minimal. Furthermore, in active bleeding cardiac ruptures, fixing the patch with run- ning sutures appears to be more effective to prevent re-rup- ture than a sutureless technique. Although this type of repair can be performed avoiding CPB, some surgeons prefer to perform it on CPB with aortic cross clamp to reduce the ten- sion on the epicardial tissue and cardiac movement, thereby favouring a quicker and more effective running suture and reducing the risk of further myocardial tearing.48 Figure 5.  Infarctectomy and closure of the defect with a prosthetic patch. After infarctectomy, a prosthetic patch is fashioned to fit this space and is sutured with pledgeted interrupted sutures. Figure 6.  Patch covering technique. A patch of pericardium is sealed on the infarcted area using surgical glue and fixed with a running Prolene® suture on the surrounding healthy myocardium.
  • 7. Matteucci et al. 385 Pocar and colleagues reported a modified patch cover- ing technique in which a Tachosil® fleece was applied to widely cover the ventricular tear and the adjacent infarcted tissue; thereafter, a generous pericardial patch was fixed with a few separate Prolene® stitches and fibrin glue was injected to seal the two layers.40 Sutureless repair Availability of tissue adhesive materials has allowed a sutureless patch technique of repair for the oozing type of ventricular rupture. A prosthetic patch, adequately fash- ioned to cover the area of haematoma and muscle necrosis, its borders placed on healthy myocardium in the peri- necrotic area, is fixed onto the myocardial surface with sur- gical glue. The glued patch must be held in place for 1 to 3 min (depending on the type of glue used), until it becomes firmly adherent and haemostatic. As reported above, a wide range of synthetic and biological glues can be used for this purpose. The obvious limitation of the biological glues is that they are effective only in the absence of active bleed- ing. So glues should preferably be used if the tear is sealed or the lesion is of the oozing type. Lachapelle et al. suggested that even patients with actively bleeding lesions can be treated using sutureless repair, provided they are on CPB with total decompression of the heart.49 Nevertheless, concerns remain over the safety of this technique when applied to treat blow-out rup- tures. In this setting, the risk of recurrent re-rupture and pseudoaneurysm formation is high, since it is very unlikely that a simply glued patch can withstand the intraventricular pressure when there is a direct communication between the left ventricular cavity and pericardial space. Recent reports are likely to shift toward the use of colla- gen sponge patch (Figure 7). A TachoComb® or Tachosil® patch is placed and pressed with wet gauze to the dry surface of the ventricle for a few minutes. When a simple patch is not large enough to cover the entire damage surface, a second patch is applied. Again, surrounding healthy myocardium not involved in the necrotic process is important to allow bet- ter anchoring and avoid re-rupture. This surgical approach, particularly when reserved to treat patients with oozing type rupture, has shown satisfactory clinical results.50,51 In conclusion, the sutureless technique is simple, fast and can be done without CPB; moreover, it preserves left ventricular geometry and, leaving the necrotic tissue untouched, provides complete haemostasis. However, before considering this approach to be safe and suitable for all types of LVFWR, further investigations are required. Percutaneous intra-pericardial fibrin-glue injection therapy Recently, a new therapeutic option, namely percutaneous intra-pericardial fibrin-glue injection therapy (PIFIT), has been introduced to the clinical setting. The use of PIFIT to enhance haemostasis in post-infarction LVFWR was first described by Ogiwara et al. in 1995.52 Fibrin-glue, compris- ing fibrinogen and thrombin, when topically applied, exerts a local haemostatic and sealant effect. It is widely used in various surgical procedures.53 PITIF for LVFWR was reported in several case reports with reasonable short- and medium-term clinical outcomes.54,55 The use of intra-peri- cardial thrombin injection, as an alternative sealant, has also been reported.56 Despite an initial concern about uncon- trolled pericardial adhesion after fibrin-glue application, reports, using serial echocardiographic follow-up, have not shown development of left ventricular restriction.54 However, Terashima et al. reported an in-hospital mortality of 25%,54 thereby, at present, such a technique should be applied only to patients with LVFWR and high surgical risk due to poor general condition. Conservative management Conservative management, in patients with sub-acute LVFWR who have recovered from cardiac tamponade (with or without pericardiocentesis) and have a prohibitive surgical risk, or when emergency surgical repair is not available, has been described. Management includes main- tenance of fluid infusion and inotropic support as needed, with early attempts at weaning within the ensuing 24 h. Figure 7.  Sutureless repair. A TachoSil® patch is applied to widely cover the ventricular wall rupture and the adjacent infarcted tissues.
  • 8. 386 European Heart Journal: Acute Cardiovascular Care 8(4) This is followed by institution of beta-blockade therapy and strict blood pressure control. Insertion of IABP, reducing left ventricular wall stress and intra-cavitary pressure, could limit infarct extension and avoid re-rupture. Prolonged bed rest has also been included in the conserva- tive management to prevent arterial hypertension or hyper- tensive crisis, often considered the precipitating causes of re-rupture.57 Subjects who survive generally have small leaks that might close spontaneously by epicardial fibrin deposits. Obviously, this kind of treatment should be con- sidered as unusual and non-standard. Blinc et al. conducted a retrospective cohort study of 107 patients who developed LVFWR; survival for the conservatively treated group was only 10%.58 By contrast, surgically treated patients had acceptable long-term survival (50%). So, surgical repair has to be considered undoubtedly the treatment of choice. Conclusion Despite the first successful LVFWR repair dating back to the year 1972, this surgical procedure continues to be asso- ciated with high in-hospital mortality rates.6 Different techniques have been developed over the years for the management of LVFWR. Nevertheless, the optimal surgical treatment for this post-AMI mechanical complica- tion remains controversial. Although the technical strategy varies, a basic principle that appears to remain unchanged is that surgeons should put the stitches, or fixed patches, in the healthy myocardial tissue. To date, sutured techniques should be considered the proce- dure of choice for surgical repair of LVFWR with active bleed- ing at the site of rupture. In the presence of oozing rupture, the most common operative finding, the sutureless technique rep- resents a safe and effective alternative option, demonstrating satisfactory outcome results. This field still has room for car- diac surgeons to improve surgical strategies and techniques. Conflict of interest RL is the Principal Investigator of PERSIST-AVR Trial sponsored by LivaNova and he is consultant for Medtronic. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. References 1. Nishiyama K, Okino S, Andou J, et al. Coronary angioplasty reduces free wall rupture and improves mortality and mor- bidity of acute myocardial infarction. J Invasive Cardiol 2004; 16: 554–548. 2. Qian G, Wu C, Chen YD, et al. Predictive factors of cardiac rupture in patients with ST-elevation myocardial infarction. J Zhejiang Univ Sci B 2014; 15: 1048–1054. 3. Padró JM, Mesa JM, Silvestre J, et al. Subacute cardiac rup- ture: Repair with a sutureless technique. Ann Thorac Surg 1993; 55: 20–23. 4. Nasir A, Gouda M, Khan A, et al. Is it ever possible to treat left ventricular free wall rupture conservatively? Interact Cardiovasc Thorac Surg 2014; 19: 488–493. 5. Terashima M, Fujiwara S, Yaginuma GY, et al. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myo- cardial infarction. Am J Cardiol 2008; 101: 419–421. 6. Formica F, Mariani S, Singh G, et al. Postinfarction left ven- tricular free wall rupture: A 17-year single-centre experience. Eur J Cardiothorac Surg 2018; 53: 150–156. 7. Sakaguchi G, Komiya T, Tamura N, et al. Surgical treat- ment for postinfarction left ventricular free wall rupture. Ann Thorac Surg 2008; 85: 1344–1346. 8. Harvey W. Complete works. Willis R (transl.) London: Sydenham Society, 1647, p.127. 9. Morgagni JB. The seat and causes of disease investigated by anatomy, vol. 1. Alexander B (transl.). London: Millar A and Caddel T, 1769, pp.811–834. 10. Montegut FJ Jr. Left ventricular rupture secondary to myo- cardial infarction. Report of survival with surgical repair. Ann Thorac Surg 1972; 14: 75–78. 11. Krumbhaar EB and Crowell C. Spontaneous rupture of the heart. Am J Med Sci 1925; 170: 828. 12. Hatcher CR Jr, Mansour K, Logan WD Jr, et al. Surgical complications of myocardial infarction. Am Surg 1970; 36: 163–170. 13. FitzGibbon GM, Hooper GD and Heggtveit HA. Successful surgical treatment of postinfarction external cardiac rupture. J Thorac Cardiovasc Surg 1972; 63: 622–630. 14. Calick A, Kerth W, Barbour D, et al. Successful surgical therapy of ruptured myocardium. Chest 1974; 66: 188. 15. Núñez L, de la Llana R, López Sendón J, et al. Diagnosis and treatment of subacute free wall ventricular rupture after infarction. Ann Thorac Surg 1983; 35: 525–529. 16. Löfström B, Mogensen L, Nyquist O, et al. 3. Attempts at emergency surgical treatment. Chest 1972; 61: 10–13. 17. Reardon MJ, Carr CL, Diamond A, et al. Ischemic left ven- tricular free wall rupture: Prediction, diagnosis, and treat- ment. Ann Thorac Surg 1997; 64: 1509–1513. 18. Pohjola-Sintonen S, Muller JE, Stone PH, et al. Ventricular septal and free wall rupture complicating acute myocardial infarction: Experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J 1989; 117: 809–818. 19. French JK, Hellkamp AS, Armstrong PW, et al. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol 2010; 105: 59–63. 20. Lancellotti P, Price S, Edvardsen T, et al. The use of echocar- diography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care 2015; 4: 3–5. 21. Porto AG, McAlindon E, Ascione R, et al. Magnetic reso- nance imaging-based management of silent cardiac rupture. J Thorac Cardiovasc Surg 2015; 149: e31–e33. 22. Villanueva C, Milder D and Manganas C. Ruptured left ventricular false aneurysm following acute myocardial infarction: Case report and review of the literature. Heart Lung Circ 2014; 23: e261–263. 23. Frances C, Romero A and Grady D. Left ventricular pseu- doaneurysm. J Am Coll Cardiol 1998; 32: 557–561.
  • 9. Matteucci et al. 387 24. Roelandt JR, Sutherland GR, Yoshida K, et al. Improved diagnosis and characterization of left ventricular pseudoa- neurysm by Doppler color flow imaging. J Am Coll Cardiol 1988; 12: 807–811. 25. Orsborne C and Schmitt M. Left ventricular pseudoaneu- rysm after myocardial infarction detected by cardiac MRI. BMJ Case Rep 2014; 2014: bcr2014207277. 26. Lazzeri C, Bernardo P, Sori A, et al. Venous-arterial extracor- poreal membrane oxygenation for refractory cardiac arrest:A clinical challenge. Eur Heart J Acute Cardiovasc Care 2013; 2: 118–126. 27. Sutherland FW, Guell FJ, Pathi VL, et al. Postinfarction ven- tricular free wall rupture: Strategies for diagnosis and treat- ment. Ann Thorac Surg 1996; 61: 1281–1285. 28. Iemura J, Oku H, Otaki M, et al. Surgical strategy for left ventricular free wall rupture after acute myocardial infarc- tion. Ann Thorac Surg 2001; 71: 201–204. 29. Mantovani V, Vanoli D, Chelazzi P, et al. Post-infarction car- diac rupture: Surgical treatment. Eur J Cardiothorac Surg 2002; 22: 777–780. 30. Leva C, Bruno PG, Gallorini C, et al. Complete myocardial revascularization and sutureless technique for left ventricu- lar free wall rupture: Clinical and echocardiographic results. Interact Cardiovasc Thorac Surg 2006; 5: 408–412. 31. Okada K, Yamashita T, Matsumori M, et al. Surgical treatment for rupture of left ventricular free wall after acute myocardial infarction. Interact Cardiovasc Thorac Surg 2005; 4: 203–206. 32. Timóteo AT, Nogueira MA, Rosa SA, et al.; ProACS Investigators. Role of intra-aortic balloon pump counterpulsa- tion in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry. Eur Heart J Acute Cardiovasc Care 2016; 5: 23–31. 33. Sousa-Uva M, Neumann FJ, Ahlsson A, et al.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocar- dial revascularization. Eur J Cardiothorac Surg 2019; 55: 4–90. 34. Canovas SJ, Lim E, Dalmau MJ, et al. Midterm clinical and echocardiographic results with patch glue repair of left ven- tricular free wall rupture. Circulation 2003; 108(Suppl. 1): II237–II240. 35. Zeebregts CJ, Noyez L, Hensens AG, et al. Surgical repair of subacute left ventricular free wall rupture. J Card Surg 1997; 12: 416–419. 36. Prêtre R, Benedikt P and Turina MI. Experience with postin- farction left ventricular free wall rupture. Ann Thorac Surg 2000; 69: 1342–1345. 37. Simo KA, Hanna EM, Imagawa DK, et al. Hemostatic agents in hepatobiliary and pancreas surgery: A review of the litera- ture and critical evaluation of a novel carrier-bound fibrin sealant (TachoSil). ISRN Surg 2012; 2012: 729086. 38. Fuglsang K, Dueholm M, Stæhr-Hansen E, et al. Uterine healing after therapeutic intrauterine administration of TachoSil (hemostatic fleece) in cesarean section with post- partum hemorrhage caused by placenta previa. J Pregnancy 2012; 2012: 635683. 39. Maisano F, Kjaergård HK, Bauernschmitt R, et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery:Arandomised controlled trial. Eur J Cardiothorac Surg 2009; 36: 708–714. 40. Pocar M, Passolunghi D, BregasiA, et al. TachoSil for postin- farction ventricular free wall rupture. Interact Cardiovasc Thorac Surg 2012; 14: 866–867. 41. Muto A, Nishibe T, Kondo Y, et al. Sutureless repair with TachoComb sheets for oozing type postinfarction cardiac rupture. Ann Thorac Surg 2005; 79: 2143–2145. 42. Byrne DJ, Hardy J, Wood RA, et al. Effect of fibrin glues on the mechanical properties of healing wounds. Br J Surg 1991; 78: 841–843. 43. Bingley JA, Gardner MA, Stafford EG, et al. Late complica- tions of tissue glues in aortic surgery. Ann Thorac Surg 2000; 69: 1764–1768. 44. Kung H. Evaluation of the undesirable side-effects of the surgical use of histoacryl glue with special regard to pos- sible carcinogenicity. Basel, Switzerland: RCC Institute for Contract Research in Toxicology and Ecology, 1986. 45. Cobbs BW Jr, Hatcher CR Jr and Robinson PH. Cardiac rup- ture. Three operations with two long-term survivals. JAMA 1973; 223: 532–535. 46. Schwarz CD, Punzengruber C, Ng CK, et al. Clinical presentation of rupture of the left-ventricular free wall after myocardial infarction: Report of five cases with suc- cessful surgical repair. Thorac Cardiovasc Surg 1996; 44: 71–75. 47. Coletti G, Torracca L, Zogno M, et al. Surgical management of left ventricular free wall rupture after acute myocardial infarction. Cardiovasc Surg 1995; 3: 181–186. 48. Haddadin S, Milano AD, Faggian G, et al. Surgical treatment of postinfarction left ventricular free wall rupture. J Card Surg 2009; 24: 624–631. 49. Lachapelle K, deVarennes B, Ergina PL, et al. Sutureless patch technique for postinfarction left ventricular rupture. Ann Thorac Surg 2002; 74: 96–101 50. Raffa GM, Tarelli G, Patrini D, et al. Sutureless repair for postinfarction cardiac rupture: A simple approach with a tissue-adhering patch. J Thorac Cardiovasc Surg 2013; 145: 598–599. 51. Bergman R, Jainandunsing JS, Woltersom BD, et al. Sutureless management of left ventricle wall rupture; a series of three cases. J Cardiothorac Surg 2014; 9: 136. 52. Ogiwara M, Kyo S, Yokote Y, et al. [Clinical result of left ventricular free wall rupture resulting from acute myocardial infarction]. Kyobu Geka 1995; 48: 286–289. 53. Spotnitz WD. Fibrin sealant: Past, present, and future: A brief review. World J Surg 2010; 34: 632–634. 54. Terashima M, Fujiwara S, Yaginuma GY, et al. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myo- cardial infarction. Am J Cardiol 2008; 101: 419–421. 55. Joho S, Asanoi H, Sakabe M, et al. Long-term usefulness of percutaneous intrapericardial fibrin-glue fixation therapy for oozing type of left ventricular free wall rupture: A case report. Circ J 2002; 66: 705–706. 56. Lee JK, Tsui KL, Chan KK, et al. Intra-pericardial thrombin injection for post-infarction left ventricular free wall rupture. Eur Heart J Acute Cardiovasc Care 2012; 1: 337–340. 57. Figueras J, Cortadellas J, Evangelista A, et al. Medical management of selected patients with left ventricular free wall rupture during acute myocardial infarction. J Am Coll Cardiol 1997; 29: 512–518. 58. Blinc A, Noc M, Pohar B, et al. Subacute rupture of the left ventricular free wall after acute myocardial infarction. Three cases of long-term survival without emergency surgical repair. Chest 1996; 109: 565–567.